Nationwide Fund Advisors’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-15,996
Closed -$660K 3346
2015
Q2
$660K Sell
15,996
-77,502
-83% -$2.78M ﹤0.01% 2090
2015
Q1
$3.29M Sell
93,498
-3,077
-3% -$104K 0.01% 1193
2014
Q4
$3.1M Sell
96,575
-193
-0.2% -$5.58K 0.01% 1185
2014
Q3
$2.71M Sell
96,768
-28,791
-23% -$877K 0.01% 1266
2014
Q2
$3.79M Sell
125,559
-4,080
-3% -$113K 0.02% 1137
2014
Q1
$3.59M Sell
129,639
-2,765
-2% -$72.4K 0.02% 1040
2013
Q4
$3.38M Buy
132,404
+40,862
+45% +$1.26M 0.01% 1167
2013
Q3
$2.73M Sell
91,542
-20
-0% -$556 0.01% 1245
2013
Q2
$2.63M Buy
+91,562
New +$2.52M 0.01% 1147

Other funds holding BRLI

Nationwide Fund Advisors's BRLI Position: Q3 2015 in Review

Nationwide Fund Advisors sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 15,996 shares — an estimated $660K sold.

Nationwide Fund Advisors first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $3.79M in Q2 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Nationwide Fund Advisors reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Nationwide Fund Advisors sold 15,996 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $660K.
  • Nationwide Fund Advisors first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • Nationwide Fund Advisors's BIO-REFERENCE LABS INC-NEW- position peaked at $3.79M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Nationwide Fund Advisors's 13F filing for Q3 2015, filed 26 Oct 2015.